ArticleOphthalmology and therapy2020

A Multicenter, Retrospective Study (RE-ENACT 2) on the Use of Razumab™ (World's First Biosimilar Ranibizumab) in Wet Age-Related Macular Degeneration.

Shashikant Sharma et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.